According to a new report published by K D Market Insights, titled, “Intradermal Injection Market Insights, Trends, Opportunity & Forecast, 2024-2032,” the global intradermal injection market size is anticipated to witness moderate growth during the forecast period i.e., 2024-2032. increasing demand for effective drug delivery methods and the rising prevalence of chronic diseases requiring frequent injections. Intradermal injections offer several advantages, including improved drug absorption, reduced pain, and enhanced patient compliances which is the major factors augmenting the growth of the global intradermal injection market.
The growing adoption of intradermal vaccination is a significant driver. Intradermal injections offer advantages such as reduced vaccine doses, improved immune response, and cost savings which is further expected to create ample growth opportunities for the global intradermal injection market during the forecast period i.e., 2024-2032. Moreover, the increasing acceptance of aesthetic procedures has propelled market expansion. Technological advancements, is expected to contribute towards the market growth during the period.
The North America region accounted for the largest share in the global intradermal injection market in 2023. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the advanced healthcare systems and a strong presence of key market players.
According to product type, the normal sized needles segment accounted for the largest market share in the intradermal injection market in 2023 and is further expected to continue with the trend during the forecast period i.e., 2024 - 2032.
The global intradermal injection market is segmented into product type, application, end user and region. Based on product, the market is bifurcated into normal sized needles, short needle (intradermal microinjection, microneedle arrays, and tattoo devices), and without needle (intradermal liquid jet devices and ballistic intradermal injectors). Based on application, it is classified into tuberculin skin test, allergy test, local aesthetics, and others. Based on end user, it is classified into hospitals, diagnostic laboratories, academics and research institutes, and others.
The global intradermal injection market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).
Key Insights of Light Therapy Market
- On the basis of product type, the normal sized needles segment accounted for the largest market share in the intradermal injection market in 2023 and is further expected to continue with the trend during the forecast period i.e., 2024 – 2032.
- On the basis of region, North America accounted for the largest share in the global intradermal injection market in 2023. The region is further projected to continue dominating in the market during the forecast period.
- On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.
Some of the major intradermal injection companies profiled in the report include Becton Dickinson, Cardinal Health, West Pharmaceuticals Services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, Hindustan Syringes and Medical Devices.
Related Reports :-
https://www.kdmarketinsights.com/reports/medical-terminology-software-market/7346
https://www.kdmarketinsights.com/reports/human-microbiome-market/7345
https://www.kdmarketinsights.com/reports/fetal-and-neonatal-care-equipment-market/7344
https://www.kdmarketinsights.com/reports/dermatology-imaging-market/7343